Rockefeller Capital Management L.P. Sells 36,941 Shares of CVS Health Co. (NYSE:CVS)

Rockefeller Capital Management L.P. trimmed its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 5.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 604,032 shares of the pharmacy operator's stock after selling 36,941 shares during the quarter. Rockefeller Capital Management L.P.'s holdings in CVS Health were worth $37,997,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. MidAtlantic Capital Management Inc. bought a new position in CVS Health during the third quarter worth $25,000. Livelsberger Financial Advisory bought a new position in CVS Health during the third quarter worth $31,000. Reston Wealth Management LLC bought a new position in CVS Health during the third quarter worth $32,000. Kathleen S. Wright Associates Inc. bought a new position in CVS Health during the third quarter worth $33,000. Finally, First Community Trust NA boosted its position in CVS Health by 116.2% during the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator's stock worth $33,000 after purchasing an additional 302 shares during the period. 80.66% of the stock is owned by institutional investors.

CVS Health Price Performance

NYSE CVS traded down $0.11 during trading on Friday, hitting $59.85. 3,947,743 shares of the company's stock were exchanged, compared to its average volume of 11,314,412. The stock's 50 day moving average price is $59.36 and its two-hundred day moving average price is $58.74. CVS Health Co. has a fifty-two week low of $52.71 and a fifty-two week high of $83.25. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The company has a market cap of $75.32 billion, a PE ratio of 15.18, a P/E/G ratio of 1.02 and a beta of 0.55.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. During the same quarter in the prior year, the firm posted $2.21 earnings per share. The firm's revenue was up 6.3% compared to the same quarter last year. Research analysts expect that CVS Health Co. will post 5.37 EPS for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.44%. The ex-dividend date was Monday, October 21st. CVS Health's dividend payout ratio is currently 67.51%.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on CVS shares. Cantor Fitzgerald reissued a "neutral" rating and issued a $62.00 target price on shares of CVS Health in a research report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft reduced their target price on shares of CVS Health from $64.00 to $63.00 and set a "hold" rating for the company in a research report on Friday, August 9th. Evercore ISI boosted their target price on shares of CVS Health from $62.00 to $75.00 and gave the company an "outperform" rating in a research report on Tuesday, October 8th. TD Cowen boosted their target price on shares of CVS Health from $73.00 to $80.00 and gave the company a "buy" rating in a research report on Monday, November 25th. Finally, Royal Bank of Canada reduced their target price on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating for the company in a research report on Friday, November 15th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and thirteen have issued a buy rating to the company's stock. According to data from MarketBeat, CVS Health currently has a consensus rating of "Moderate Buy" and an average target price of $70.33.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.